| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/25/2013 | CN103328511A Anti-Il-1 beta antibodies and methods of use |
| 09/25/2013 | CN103328486A Fused aminodihydrothiazine derivatives useful as BACE inhibitors |
| 09/25/2013 | CN103328482A New bicyclic compound for modulating G protein-coupled receptors |
| 09/25/2013 | CN103328454A 1,4 oxazines as BACE1 and/or BACE2 inhibitors |
| 09/25/2013 | CN103328450A Crystalline pharmaceutically active ingredients |
| 09/25/2013 | CN103328449A Novel tetrahydroquinoline derivatives |
| 09/25/2013 | CN103328006A Preparation comprising insulin, nicotinamide and an amino acid |
| 09/25/2013 | CN103327995A Composition comprising fermented tea extracts for reducing lipid level |
| 09/25/2013 | CN103327977A Therapeutic or prophylactic agent for cachexia |
| 09/25/2013 | CN103320301A Health-preserving health-care fruit vinegar and its preparation method |
| 09/25/2013 | CN103320293A Formula and preparation method of Chinese medicine health-care wine |
| 09/25/2013 | CN103320284A A cactus-shiitake health-care wine and a preparation method thereof |
| 09/25/2013 | CN103319479A Rheinic acid berberine ion pair compound, preparation method and applications |
| 09/25/2013 | CN103319445A Crystal structure of SGLT2 inhibitor and preparation method of crystal structure |
| 09/25/2013 | CN103319430A Pinane-based isoxazoline compound as well as synthesis method and application thereof |
| 09/25/2013 | CN103319408A Compounds for preventing and treating cardiovascular diseases |
| 09/25/2013 | CN103316422A Hemorrhoid mat of weight losing seat |
| 09/25/2013 | CN103316345A Use melanocortins to treat insulin sensitivity |
| 09/25/2013 | CN103316301A Method for removing bitter taste of turmeric |
| 09/25/2013 | CN103316276A Processing method of prepared rehmannia root decoction piece |
| 09/25/2013 | CN103316233A Traditional Chinese medicine used for treating diabetes, and preparation method thereof |
| 09/25/2013 | CN103316194A Dracaena cambodiana leaf superfine pure powder, preparation method therefor, and preparations thereof |
| 09/25/2013 | CN103316158A Sliming compound essential oil |
| 09/25/2013 | CN103316156A Externally-used medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof |
| 09/25/2013 | CN103316152A Adjuvant hypoglycemic composition and methods for preparing and detecting the same |
| 09/25/2013 | CN103316148A Applications of Tianshen capsules in preparation of drug used for treating type 2 diabetes lipid metabolic disorders and atherosclerosis |
| 09/25/2013 | CN103316144A Chinese medicine composition capable of invigorating qi and blood, nourishing yin and yang, improving immunity, resisting to fatigue and inhibiting thrombogenesis |
| 09/25/2013 | CN103316107A Chinese herbal external-application agent for treating obesity |
| 09/25/2013 | CN103316101A Traditional Chinese medicine for treating diabetic nephropathy and preparation method thereof |
| 09/25/2013 | CN103316091A Processing method of prepared fleece flower root decoction piece |
| 09/25/2013 | CN103316065A Dandelion fluid decoction pieces and preparation method thereof |
| 09/25/2013 | CN103316057A Soup for resisting cancer and senescence, and treating burn and scald, and preparation method thereof |
| 09/25/2013 | CN103316031A Weight reduction and body fat reduction applications of chitosan oligosaccharide |
| 09/25/2013 | CN103316026A Combined product containing phentermine and topiramate, and preparation method thereof |
| 09/25/2013 | CN103316025A Application of p-hydroxyl acetophenone glycosidase to medicine for autoimmunity disease and transplant rejection disease |
| 09/25/2013 | CN103316018A Applications of latanoprost in preparation of medications for treating diabetes and/or hypertriglyceridemia and complications thereof |
| 09/25/2013 | CN103316017A Bis(alpha-furancarboxylato)oxovanadium composition for treatment of diabetes |
| 09/25/2013 | CN103316014A Specific acupuncture function composite material, preparation method thereof and applications |
| 09/25/2013 | CN103316004A Pharmaceutical composition used for preventing and controlling metabolic syndrome and application thereof |
| 09/25/2013 | CN103315999A Compound amino acid composition and preparation method thereof |
| 09/25/2013 | CN103315998A Pharmaceutical composition containing 18 kinds of amino acids |
| 09/25/2013 | CN103315997A Pharmaceutical composition containing 18 kinds of amino acids |
| 09/25/2013 | CN103315982A Usage of magnolol as CYP2E1 enzyme inhibitor |
| 09/25/2013 | CN103315971A Acarbose tablets and preparation method thereof |
| 09/25/2013 | CN103315956A Mustard oil nanoemulsion and preparation method thereof |
| 09/25/2013 | CN103315953A Fenofibrate self-microemulsifying preparation and preparation method thereof |
| 09/25/2013 | CN103315287A Food therapy for three high diseases (hypertension, hyperglycemia and hyperlipidemia) |
| 09/25/2013 | CN103315111A Health tea capable of preventing hypertension, hyperlipidemia and hyperglycemia |
| 09/25/2013 | CN103315106A Making method of bagged tea for reducing blood pressure and blood fat |
| 09/25/2013 | CN103315088A Slimming tea |
| 09/25/2013 | CN103315087A Slimming tea |
| 09/25/2013 | CN103314925A Method for preparing rhesus monkey type 2 diabetic model |
| 09/25/2013 | CN102920702B Dihydroartemisinin and Chinese blister beetle composition, enteric preparation and application and preparation thereof |
| 09/25/2013 | CN102885900B Composite with weight loss function and preparation method of composite |
| 09/25/2013 | CN102755348B Carbohydrate and electrolyte injection and preparation method thereof |
| 09/25/2013 | CN102698248B Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method |
| 09/25/2013 | CN102631665B Pharmaceutical composition of alanyl glutamine injection and compound amino acid injection |
| 09/25/2013 | CN102614280B Chinese medicinal composition with blood fat reducing effect, and preparation method and application thereof |
| 09/25/2013 | CN102552527B Traditional Chinese medicine composition used for treating diabetic complications and reducing blood sugar and preparation method thereof |
| 09/25/2013 | CN102526617B Chinese herbal medicine powder for lipid reduction and thrombolysis |
| 09/25/2013 | CN102526592B Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and immune dysfunction |
| 09/25/2013 | CN102416029B Ginseng submicron powder and preparation method and preparation thereof |
| 09/25/2013 | CN102397304B Application of Chinese herbal medicine ginkgo biloba extract in preparation of medicament for reducing weight and lipid or preparation of medicament with lipase activity inhibitory action |
| 09/25/2013 | CN102357131B Method for preparing astragalus polysaccharide glucose-lowering capsule |
| 09/25/2013 | CN101904834B Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
| 09/25/2013 | CN101293888B Xanthine derivative, production and use thereof as a medicament |
| 09/24/2013 | US8541453 Modulators of ATP-binding cassette transporters |
| 09/24/2013 | US8541427 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| 09/24/2013 | US8541425 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 09/24/2013 | US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/24/2013 | US8541392 Polymer controlled induced viscosity fiber system and uses thereof |
| 09/24/2013 | US8541368 Glucagon analogues |
| 09/24/2013 | CA2746746C Arylcyclopropylacetamide derivatives useful as glucokinase activators |
| 09/24/2013 | CA2745721C Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators |
| 09/24/2013 | CA2691691C Compositions and methods of treating chronic kidney disease |
| 09/24/2013 | CA2489090C Nutritional composition for detoxification and cancer prevention |
| 09/24/2013 | CA2488394C Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/19/2013 | WO2013138568A1 Liver x reception modulators |
| 09/19/2013 | WO2013138565A1 Liver x receptor modulators |
| 09/19/2013 | WO2013138409A1 Red yeast rice extract high in monacolin k content |
| 09/19/2013 | WO2013137832A1 Myostatin inhibitors |
| 09/19/2013 | WO2013137628A1 Novel diacylglycerol acyltransferase-2 inhibiting material, and use thereof |
| 09/19/2013 | WO2013137371A1 Novel pyrimidine compound and medicine comprising same |
| 09/19/2013 | WO2013136871A1 Oversulfated chondroitin composition |
| 09/19/2013 | WO2013136257A1 Herbal composition for the treatment of metabolic disorders |
| 09/19/2013 | WO2013135803A1 Thiophene-based compounds exhibiting nox4 inhibitory activity and use thereof in therapy |
| 09/19/2013 | WO2013100821A3 Agent for treating diabetes |
| 09/19/2013 | WO2012127498A9 A novel herbal composition for the treatment of kidney stone and other urinary tract disorders |
| 09/19/2013 | US20130245601 Intradermal delivery of substances |
| 09/19/2013 | US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/19/2013 | US20130245043 Substituted imidazopyrimidin-5(6h)-ones as allosteric modulators of mglur5 receptors |
| 09/19/2013 | US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/18/2013 | EP2638913A1 Method for producing bioactive agent, bioactive agent produced thereby, cosmetic, freshness-maintaining agent, growth promotion agent, soil conditioning agent, and pharmaceutical stock solution |
| 09/18/2013 | EP2638903A1 Suppressor for increase in blood glucose level |
| 09/18/2013 | EP2638036A1 Compound for increasing kinase active and application thereof |
| 09/18/2013 | EP2638023A1 Crystalline solids of a metap-2 inhibitor and methods of making and using same |